Pharmacological evidence supporting a role for galanin in cognition and affect.
1. Galanin is localized in brain pathways involved in both cognition and affect. 2. Galanin has inhibitory actions on a variety of memory tasks including the Morris water maze, delayed nonmatching to position, T-maze delayed alternation, starburst maze, passive avoidance, active avoidance, and spontaneous alternation. 3. Galanin may inhibit learning and memory by inhibiting neurotransmitter release and neuronal firing rate. 4. Two signal transduction mechanisms through which galanin exerts its inhibitory actions are the inhibition of phosphatidyl inositol hydrolysis and the inhibition of adenylate cyclase. 5. Galanin released during periods of burst firing from noradrenergic locus coeruleus terminals in the ventral tegmental area (VTA) may lead to symptoms of depression through inhibition of dopaminergic VTA neurons. 6. Intraventricular galanin has anxiolytic effects in a punished drinking test. Intra-amygdala galanin has anxiogenic effects in a punished drinking test.
Section on Behavioral Neuropharmacology, Experimental Therapeutics Branch, National Institute of Mental Health, Bethesda, MD 20892-1375, USA.
C C
CC
Wrenn
J N
JN
Crawley
D000339:Affect / Q000502:physiology*; D000818:Animals; D001007:Anxiety / Q000503:physiopathology; D003071:Cognition / Q000187:drug effects / Q000502:physiology*; D003863:Depression / Q000503:physiopathology; D019004:Galanin / Q000494:pharmacology / Q000502:physiology*; D006801:Humans; D018782:Maze Learning / Q000187:drug effects / Q000502:physiology; D008568:Memory / Q000187:drug effects / Q000502:physiology*; D018377:Neurotransmitter Agents / Q000502:physiology; D015398:Signal Transduction
D018377:Neurotransmitter Agents; D019004:Galanin